Navigation Links
Quest Diagnostics Again Named to FORTUNE Magazine's 'World's Most Admired Companies' List
Date:3/3/2009

Ranks second overall and first for long-term investment and social responsibility in industry category

MADISON, N.J., March 3 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, has again been named to FORTUNE magazine's list of the World's Most Admired Companies. Quest Diagnostics ranked second in the "Health Care" category of "Pharmacy and Other Services." The 2009 ranking is the second consecutive year that the company has been included on FORTUNE's Most Admired Companies list. The company advanced to second place from third in 2008. The new World's Most Admired Companies list is widely considered the definitive report card on corporate reputations.

"This prestigious recognition reflects the dedicated efforts of our 43,000 employees to put patients first and provide superior diagnostic services," said Surya N. Mohapatra, Ph.D., Chairman and CEO of Quest Diagnostics. "We are particularly gratified to have ranked number one in our industry category for long-term investment, which demonstrates support for our strategy and vision."

FORTUNE's list of the World's Most Admired Companies is based on surveys of more than 4,000 executives, directors and securities analysts of companies they admire most in their industry based on nine criteria: innovation, people management, use of corporate assets, quality of management; social responsibility; financial soundness, long-term investment, quality of products and services, and global competitiveness. For 2009, FORTUNE published one list rather than separate World's Most Admired and America's Most Admired lists in order to better represent the competitive landscape faced by today's companies.

The full list and related stories appear in the March 16 issue of FORTUNE, available on newsstands on Monday, March 9th, and now at: http://money.cnn.com/magazines/fortune/mostadmired/2009/index.html

About Quest Diagnostics

Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at www.questdiagnostics.com.

The statements in this press release that are not historical facts or information may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results and outcomes to be materially different. Certain of these risks and uncertainties may include, but are not limited to, competitive environment, changes in government regulations, changing relationships with customers, payers, suppliers and strategic partners and other factors described in the Quest Diagnostics Incorporated 2007 Form 10-K and subsequent SEC filings.


'/>"/>
SOURCE Quest Diagnostics Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FRC Action Questions President Obamas Choice of Gov. Sebelius for HHS
2. Presidents 2010 Budget Request Strongly Supports VA Programs
3. An Athletes First Question: Doc, When Can I Return?
4. Six Questions Consumers Should Ask About Genetic Tests
5. Virtual studies answer real questions
6. Findings raise new questions about evolution of hormones in mammals
7. Charleston Conducts Evaluation of an Opioid Symptoms Questionnaire
8. C4CC Education Fund Launches Discussion Forum for Consumers With Health Insurance Questions
9. SurgiQuest Announces FDA Approval for Smoke & Plume Evacuation for AirSeal Dynamic Pressure System(TM)
10. Study questions effectiveness of $80 million per year brain exercise products industry
11. ANA and ISONG Co-Publish Genetics and Ethics in Health Care: New Questions in the Age of Genomic Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... 21, 2017 , ... "ProDOF is the perfect set of tools for video editors that want ... scene," said Christina Austin - CEO of Pixel Film Studios. , Video editors using ... illusion of a DSLR racking focus from one area into the next. ProDOF comes ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual meeting “Coming ... friends, and community. “Coming Home 2017” will be held on Friday January ...
(Date:1/21/2017)... ... January 21, 2017 , ... In the United States, ... experience the freedom of recovery, they often feel shame for having struggled with an ... disorder (PTSD). In the workshop, “Rising Strong in Life After an Eating Disorder” -- ...
(Date:1/20/2017)... , ... January 20, 2017 , ... A new partnership ... items they no longer use or need, from clothes to couches to dressers and ... items and take them to the nearest Goodwill donation center through February 28th. ...
(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... Doctor ... announced it attended the January ECRM trade show to continue the marketing and distribution ... vitamin C supplement, known for providing 400 percent better absorption than traditional vitamin C ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... NEW YORK , Jan. 19, 2017 /PRNewswire/ ... reach USD 233.7 billion by 2025, according to ... The market is anticipated to be predominantly driven ... companies, resulting into the large-scale production of new ... widen the influx of drugs at an unprecedented ...
(Date:1/19/2017)... Conference Call and Webcast to Follow Vanda Pharmaceuticals Inc. ... results for the fourth quarter of 2016 on Wednesday, February 15, ... ... PM ET on Wednesday, February 15, 2017, during which management will ... other corporate activities. To participate in the conference call, please dial ...
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
Breaking Medicine Technology: